| Literature DB >> 26114571 |
Amber J Marty1, Aimee T Broman2, Robert Zarnowski1, Teigan G Dwyer1, Laura M Bond3, Anissa Lounes-Hadj Sahraoui4, Joël Fontaine4, James M Ntambi5, Sündüz Keleş6, Christina Kendziorski2, Gregory M Gauthier1.
Abstract
In response to temperature, Blastomyces dermatitidis converts between yeast and mold forms. Knowledge of the mechanism(s) underlying this response to temperature remains limited. In B. dermatitidis, we identified a GATA transcription factor, SREB, important for the transition to mold. Null mutants (SREBΔ) fail to fully complete the conversion to mold and cannot properly regulate siderophore biosynthesis. To capture the transcriptional response regulated by SREB early in the phase transition (0-48 hours), gene expression microarrays were used to compare SREB∆ to an isogenic wild type isolate. Analysis of the time course microarray data demonstrated SREB functioned as a transcriptional regulator at 37°C and 22°C. Bioinformatic and biochemical analyses indicated SREB was involved in diverse biological processes including iron homeostasis, biosynthesis of triacylglycerol and ergosterol, and lipid droplet formation. Integration of microarray data, bioinformatics, and chromatin immunoprecipitation identified a subset of genes directly bound and regulated by SREB in vivo in yeast (37°C) and during the phase transition to mold (22°C). This included genes involved with siderophore biosynthesis and uptake, iron homeostasis, and genes unrelated to iron assimilation. Functional analysis suggested that lipid droplets were actively metabolized during the phase transition and lipid metabolism may contribute to filamentous growth at 22°C. Chromatin immunoprecipitation, RNA interference, and overexpression analyses suggested that SREB was in a negative regulatory circuit with the bZIP transcription factor encoded by HAPX. Both SREB and HAPX affected morphogenesis at 22°C; however, large changes in transcript abundance by gene deletion for SREB or strong overexpression for HAPX were required to alter the phase transition.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26114571 PMCID: PMC4482641 DOI: 10.1371/journal.ppat.1004959
Source DB: PubMed Journal: PLoS Pathog ISSN: 1553-7366 Impact factor: 6.823
Gene ontology (GO) enrichment analysis.
| GO Term | GO ID | 37°C | 22°C | ||
|---|---|---|---|---|---|
| Yeast | 6-hrs | 24-hrs | 48-hrs | ||
|
| |||||
| Iron Ion Binding | GO:0005506 | X (0.019) | — | X (0.002) | — |
| Catalytic Activity | GO:0003824 | — | X (< 0.001) | X (< 0.001) | X (< 0.001) |
| Oxidoreductase Activity | GO:0016491 | — | X (0.006) | X (< 0.001) | X (< 0.001) |
| FAD binding | GO:0050660 | — | X (0.092) | — | X (0.093) |
| Amino Acid Transmembrane Transporter Activity | GO:0015171 | — | — | X (0.018) | X (0.097) |
| Hydrolase Activity, hydrolyzing O-glycosyl compounds | GO:0004553 | — | — | X (0.048) | X (0.051) |
| Transporter Activity | GO:0005215 | — | — | X (0.057) | X (0.079) |
|
| |||||
| Transmembrane Transport | GO:0055085 | X (0.092) | — | X (< 0.001) | X (< 0.001) |
| Metabolic Process | GO:0008152 | — | X (< 0.001) | X (< 0.001) | X (< 0.001) |
| Oxidation-Reduction Process | GO:0055114 | — | X (0.092) | X (< 0.001) | X (< 0.001) |
| Fatty Acid Biosynthetic Process | GO:0006633 | — | — | X (0.018) | — |
| Amino Acid Transport | GO:0006865 | — | — | X (0.018) | X (0.097) |
| Transport | GO:0006810 | — | — | — | X (0.008) |
| Carbohydrate Metabolic Process | GO:0005975 | — | — | — | X (0.097) |
|
| |||||
| Integral to Membrane | GO:0016021 | X (0.092) | X (0.006) | — | X (0.011) |
| Membrane | GO:0016020 | — | — | X (0.028) | X (0.006) |
| Endoplasmic Reticulum | GO:0005783 | — | — | X (0.043) | — |
X indicates enrichment. Numbers in parentheses are q-values. “—” indicates no enrichment. GO ID refers to gene ontology identification number.
Differentially expressed (DE) genes in SREB∆ versus wild type at 37°C and 22°C.
| Fold change of DE genes | ||||||
|---|---|---|---|---|---|---|
| DE Genes | ≥1.5 | ≥2.0 | ≥3.0 | ≥4.0 | ≥5.0 | |
| Yeast 37°C | 1,410 | 1,403 (99.5%) | 912 (64.7%) | 315 (22.3%) | 156 (11.1%) | 112 (7.9%) |
| ↑Transcription | 859 | 853 | 550 | 182 | 79 | 55 |
| ↓Transcription | 551 | 550 | 362 | 133 | 77 | 57 |
| 6-hours 22°C | 1,109 | 1,109 (100%) | 678 (61.1%) | 217 (19.6%) | 100 (9.0%) | 69 (6.2%) |
| ↑Transcription | 596 | 596 | 375 | 124 | 61 | 41 |
| ↓Transcription | 513 | 513 | 303 | 93 | 39 | 28 |
| 24-hours 22°C | 1,772 | 1,755 (99.0%) | 1108 (62.5%) | 417 (23.5%) | 203 (11.5%) | 104 (5.9%) |
| ↑Transcription | 823 | 815 | 513 | 207 | 101 | 55 |
| ↓Transcription | 949 | 940 | 595 | 210 | 102 | 49 |
| 48-hours 22°C | 1,910 | 1,869 (97.9%) | 1,076 (56.3%) | 403 (21.1%) | 203 (10.6%) | 115 (6.0%) |
| ↑Transcription | 963 | 939 | 537 | 217 | 118 | 70 |
| ↓Transcription | 947 | 930 | 539 | 186 | 85 | 45 |
DE Genes refers to genes determined to be DE by both LIMMA and EBarrays analyses (FDR controlled at 5%)
Fold change values reflect median fold change between SREB∆ and wild-type and includes genes with increased and decreased transcription. Fold change values of 1.5, 2.0, 3.0, 4.0, and 5.0 correspond to log2 fold change of 0.585, 1.000, 1.585, 2.000, and 2.322 in S1 Table, respectively.
Weighted gene co-expression network analysis.
| Module Color | Enriched GO term |
|
| % DE |
|---|---|---|---|---|
| Midnight blue |
| 3.45 x10-10 | < 0.001 | 84.6% (209/247) |
| Green yellow |
| 9.48 x 10−8 / 6.07 x 10−7 | < 0.001 / < 0.001 | 70.1% (246/351) |
| Turquoise | Transcription factor activity | 2.94e-6 | 0.001 | 55.1% (534/978) |
| Blue |
| 2.69 x 10−6 | 0.001 | 53.5% (490/916) |
| Black | SC Ribo / Translation | 7.15 x 10−59 / 4.47 x 10−45 | < 0.001 / < 0.001 | 47.4% (203/428) |
| Light cyan | Cellular metabolic process | 2.1 x 10−11 | 0.001 | 42.7% (102/239) |
| Yellow | Nucleic acid binding | 2.52 x 10−11 | < 0.001 | 26.6% (166/624) |
| Tan | Hydrolase (acid anhydrides) | 0.000282 | 0.001 | 23.1% (68/295) |
| Pink | Signal transduction | 3.07 x 10−6 | 0.001 | 13.9% (59/424) |
| Light yellow | DNA replication | 5.6 x 10−17 | < 0.001 | 8.7% (17/195) |
| Orange | Nucleosome | 0.00151 | 0.025 | 0.9% (1/117) |
SC Ribo is structural constituent of ribosome; FA bio is fatty acid biosynthesis. Underlined modules and GO terms were also identified in the GO enrichment analysis in Table 2.